We are live on
!
Find out more
ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Est. Return
7.38%
This Fund
S&P 500
This Quarter
Est. Return
+11.21%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$243M
Cap. Flow
% of AUM
95.38%
Top 10 Holdings %
Top 10 Hldgs %
38.34%
Holding
87
New
87
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$14.7M |
| 2 |
Becton Dickinson
BDX
|
+$11.7M |
| 3 |
AGN
Allergan plc
AGN
|
+$9.93M |
| 4 |
Encompass Health
EHC
|
+$9.24M |
| 5 |
Elevance Health
ELV
|
+$9.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 85.71% |
| 2 | Technology | 1.03% |
| 3 | Financials | 0.67% |
| 4 | Consumer Staples | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Thermo Fisher Scientific
TMO
$213B
| $15.2M | 5.95% |
+120,950
| New | +$14.7M |
|
|
2
Becton Dickinson
BDX
$45.6B
| $12.4M | 4.87% |
+91,492
| New | +$11.7M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $10.2M | 4.01% |
+39,747
| New | +$9.93M |
|
4
Universal Health Services
UHS
$10.2B
| $9.53M | 3.74% |
+85,675
| New | +$9M |
|
|
5
Elevance Health
ELV
$81.5B
| $9.19M | 3.61% |
+73,135
| New | +$9.04M |
|
6
Community Health Systems
CYH
$393M
| $9.13M | 3.58% |
+204,793
| New | +$8.76M |
|
|
7
Encompass Health
EHC
$11B
| $9.07M | 3.56% |
+296,323
| New | +$9.24M |
|
8
Labcorp
LH
$25B
| $7.84M | 3.08% |
+84,613
| New | +$7.47M |
|
9
Teva Pharmaceuticals
TEVA
$40.8B
| $7.64M | 3% |
+132,900
| New | +$7.4M |
|
10
Medtronic
MDT
$109B
| $7.52M | 2.95% |
+104,200
| New | +$7.24M |
|
11
McKesson
MCK
$100B
| $6.88M | 2.7% |
+33,140
| New | +$6.73M |
|
12
Novartis
NVS
$297B
| $6.6M | 2.59% |
+79,459
| New | +$6.59M |
|
|
HOLX
13
DELISTED
Hologic
HOLX
| $6.11M | 2.4% |
+228,540
| New | +$5.9M |
|
14
Cardinal Health
CAH
$53.9B
| $5.88M | 2.31% |
+72,800
| New | +$5.75M |
|
15
Quest Diagnostics
DGX
$25.7B
| $5.57M | 2.18% |
+83,000
| New | +$5.24M |
|
16
Globus Medical
GMED
$10.7B
| $5M | 1.96% |
+210,300
| New | +$4.66M |
|
|
EVHC
17
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $4.09M | 1.6% |
+39,382
| New | +$4.05M |
|
|
VOLC
18
DELISTED
VOLCANO CORPORATION COM STK
VOLC
| $3.98M | 1.56% |
+222,350
| New | +$2.67M |
|
|
BCR
19
DELISTED
CR Bard Inc.
BCR
| $3.95M | 1.55% |
+23,699
| New | +$3.83M |
|
|
AGN
20
DELISTED
Allergan Inc
AGN
| $3.79M | 1.49% |
+17,850
| New | +$3.55M |
|
|
MDRX
21
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.69M | 1.45% |
+288,950
| New | +$3.68M |
|
22
UnitedHealth
UNH
$376B
| $3.65M | 1.43% |
+36,100
| New | +$3.42M |
|
23
Biogen
BIIB
$30B
| $3.26M | 1.28% |
+9,612
| New | +$3.11M |
|
24
Viatris
VTRS
$20.4B
| $3.15M | 1.24% |
+55,900
| New | +$3M |
|
|
MNK
25
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $2.98M | 1.17% |
+30,109
| New | +$2.77M |
|
Similar funds
VAFP
CA
SCM
FWM
TOPU
CCMU
TGI
HSCU
Endurant Capital Management's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Endurant Capital Management, which disclosed 87 positions worth $255M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Thermo Fisher Scientific: 120,950 shares worth $15.2M.
By sector, the portfolio is most concentrated in Healthcare at 86% of assets, followed by Technology and Financials.
- Endurant Capital Management's largest Q4 2014 buy was Thermo Fisher Scientific: 120,950 shares worth $15.2M.
- Endurant Capital Management's ten largest holdings make up 38% of its $255M portfolio in Q4 2014.
- Endurant Capital Management disclosed 87 positions in Q4 2014, its first 13F filing on record.
Based on Endurant Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.